A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain

Fibromyalgia (FM), is associated with fatigue, chronic diffuse pain, and cognitive/mood disturbances [1,2]. FM patients have greater healthcare costs and reduced workplace productivity. Stress and the neurotransmitter dopamine may interact, and this interaction may induce FM. Interestingly, FM has been called a ‘stress-related disorder’ presenting an exacerbation of symptoms on the context of stressful events [3].Certainly, many genes are involved in FM causation and potential predisposition. However, it is important to realize that epigenetics may also be involved in the progression of this disorder. Specifically, Menzies

• Publication year

  2014

• Venue

  Journal of genetic syndrome & gene therapy

• Publication date

  2014-01-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2157-7412.1000213PMID 24883230PMCID 4039556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Have We Hatched the Addiction Egg: Reward Deficiency Syndrome Solution System™

  2013cited by this paper
• 147. Effects of maternal immune activation on embryonic hypothalamic development

  2013influential reference
• Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: a preliminary report.

  2013cited by this paper
• Council for the Advancement of Nursing Science Gene expression profiles of fatigued fibromyalgia patients with different categories of pain and catastrophizing: A preliminary report

  2013cited by this paper
• Candidate gene studies of fibromyalgia: a systematic review and meta-analysis

  2012cited by this paper
• Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.

  2012cited by this paper
• Multilocus Genetic Composite Reflecting Dopamine Signaling Capacity Predicts Reward Circuitry Responsivity

  2012cited by this paper
• Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

  2012cited by this paper
• The comparative burden of mild, moderate and severe Fibromyalgia: results from a cross-sectional survey in the United States

  2011cited by this paper
• Genetics and Gene Expression Involving Stress and Distress Pathways in Fibromyalgia with and without Comorbid Chronic Fatigue Syndrome

  2011influential reference
• Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands

  2008cited by this paper
• Stress and dopamine: implications for the pathophysiology of chronic widespread pain.

  2004cited by this paper
• Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.

  2001cited by this paper
• DL-phenylalanine markedly potentiates opiate analgesia - an example of nutrient/pharmaceutical up-regulation of the endogenous analgesia system.

  2000cited by this paper
• Long-lasting delayed hyperalgesia after subchronic swim stress.

  2000influential reference
• Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception.

  1999influential reference
• Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress.

  1995cited by this paper
• [Enkephalinase mechanisms of tolerance of analgetic action of opioids. Effects of D-phenylalanine and naloxone].

  1994cited by this paper
• [Enkephalinase mechanisms of tolerance of analgetic action of opioids. Effects of D-phenylalanine and naloxone].

  1994cited by this paper
• The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease.

  1992cited by this paper
• Enkephalinase inhibition: regulation of ethanol intake in genetically predisposed mice.

  1987cited by this paper
• Analgesic properties of enkephalinase inhibitors: animal and human studies.

  1985cited by this paper

• Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

  2021cites this paper
• RESEARCH AND REVIEWS: JOURNAL OF ENGINEERING AND TECHNOLOGY Genetic syndromes and Involvement of Gene Therapy

  2015cites this paper
• Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?

  2014cites this paper